NO913687L - Nye insulinforbindelser. - Google Patents

Nye insulinforbindelser.

Info

Publication number
NO913687L
NO913687L NO91913687A NO913687A NO913687L NO 913687 L NO913687 L NO 913687L NO 91913687 A NO91913687 A NO 91913687A NO 913687 A NO913687 A NO 913687A NO 913687 L NO913687 L NO 913687L
Authority
NO
Norway
Prior art keywords
image
connections
coded
amino acid
acid residue
Prior art date
Application number
NO91913687A
Other languages
English (en)
Other versions
NO300640B1 (no
NO913687D0 (no
Inventor
Per Balschmidt
Finn Benned Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO913687D0 publication Critical patent/NO913687D0/no
Publication of NO913687L publication Critical patent/NO913687L/no
Publication of NO300640B1 publication Critical patent/NO300640B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO913687A 1989-03-20 1991-09-19 Fremgangsmåte ved fremstilling av nye insulinforbindelser NO300640B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK134189A DK134189D0 (da) 1989-03-20 1989-03-20 Insulinforbindelser
PCT/DK1990/000071 WO1990011299A1 (en) 1989-03-20 1990-03-15 Novel insulin compounds

Publications (3)

Publication Number Publication Date
NO913687D0 NO913687D0 (no) 1991-09-19
NO913687L true NO913687L (no) 1991-11-19
NO300640B1 NO300640B1 (no) 1997-06-30

Family

ID=8103787

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913687A NO300640B1 (no) 1989-03-20 1991-09-19 Fremgangsmåte ved fremstilling av nye insulinforbindelser

Country Status (23)

Country Link
US (1) US5430016A (no)
EP (1) EP0463072B1 (no)
JP (1) JPH04503808A (no)
KR (1) KR920701250A (no)
CN (1) CN1045793A (no)
AT (1) ATE116661T1 (no)
AU (1) AU637365B2 (no)
CA (1) CA2049961A1 (no)
DD (1) DD298788A5 (no)
DE (1) DE69015811T2 (no)
DK (2) DK134189D0 (no)
ES (1) ES2068384T3 (no)
FI (1) FI914419A0 (no)
GR (1) GR1002545B (no)
HU (1) HUT58349A (no)
IE (1) IE66564B1 (no)
IL (1) IL93792A0 (no)
NO (1) NO300640B1 (no)
NZ (1) NZ232953A (no)
PT (1) PT93502B (no)
WO (1) WO1990011299A1 (no)
YU (1) YU53290A (no)
ZA (1) ZA902086B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US5304473A (en) * 1991-06-11 1994-04-19 Eli Lilly And Company A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
NZ245170A (en) * 1991-11-26 1994-07-26 Lilly Co Eli Insulin and proinsulin analogues with arg at b31, b32 and ao and pharmaceutical compositions
US5948751A (en) * 1996-06-20 1999-09-07 Novo Nordisk A/S X14-mannitol
JP2001521006A (ja) 1997-10-24 2001-11-06 イーライ・リリー・アンド・カンパニー 不溶性インシュリン組成物
US6531448B1 (en) 1997-12-23 2003-03-11 Eli Lilly And Company Insoluble compositions for controlling blood glucose
US7378390B2 (en) * 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
CZ2004710A3 (cs) * 2001-12-20 2005-02-16 Eli Lilly And Company Inzulínová sloučenina s protrahovaným účinkem
EP1620465A2 (en) * 2003-04-29 2006-02-01 Eli Lilly And Company Insulin analogs having protracted time action
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
EP2131723B1 (en) * 2007-03-19 2013-07-24 Insuline Medical Ltd. Device for substance measurement
WO2009081262A1 (en) * 2007-12-18 2009-07-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
CN104069567A (zh) * 2007-03-19 2014-10-01 茵苏莱恩医药有限公司 药物输送设备
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
MY152979A (en) 2008-01-09 2014-12-15 Sanofi Aventis Deutschland Novel insulin derivatives having an extremely delayed time-action profile
JP5695909B2 (ja) 2008-01-09 2015-04-08 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体
RS59913B1 (sr) 2008-10-17 2020-03-31 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
AU2009312474B2 (en) 2008-11-07 2014-12-04 Insuline Medical Ltd. Device and method for drug delivery
CN102596175A (zh) 2009-07-06 2012-07-18 赛诺菲-安万特德国有限公司 含有甲硫氨酸的水性胰岛素制备物
PT3345593T (pt) 2009-11-13 2023-11-27 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina
MY180661A (en) 2009-11-13 2020-12-04 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
PL2611458T3 (pl) 2010-08-30 2017-02-28 Sanofi-Aventis Deutschland Gmbh Zastosowanie AVE0010 do produkcji leku do leczenia cukrzycy typu 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
AU2014261111B2 (en) 2013-05-02 2017-03-16 Glaxosmithkline Intellectual Property Development Limited Therapeutic peptides
EP3229828B1 (en) 2014-12-12 2023-04-05 Sanofi-Aventis Deutschland GmbH Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN106323840A (zh) * 2016-09-13 2017-01-11 西南石油大学 一种页岩孔隙度测量方法
CN109735589B (zh) * 2019-01-02 2020-07-10 珠海冀百康生物科技有限公司 一种胰岛素DesB30的制备方法
CN113773398B (zh) * 2020-06-10 2023-05-23 宁波鲲鹏生物科技有限公司 一种德谷胰岛素衍生物及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55138393A (en) * 1979-04-13 1980-10-29 Shionogi & Co Ltd Semisynthesis of insulin
IE50892B1 (en) * 1980-02-11 1986-08-06 Novo Industri As Process for preparing insulin esters
DK147437A (en) * 1980-02-11 1900-01-01 Process for preparing human insulin or threonine B30 esters of human insulin, or a salt or complex thereof
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3327709A1 (de) * 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK113585D0 (da) * 1985-03-12 1985-03-12 Novo Industri As Nye peptider
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DK347086D0 (da) * 1986-07-21 1986-07-21 Novo Industri As Novel peptides
US4946828A (en) * 1985-03-12 1990-08-07 Novo Nordisk A/S Novel insulin peptides
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
DE3717370A1 (de) * 1987-05-22 1988-12-01 Hoechst Ag Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
DK336188D0 (da) * 1988-06-20 1988-06-20 Nordisk Gentofte Propeptider
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung

Also Published As

Publication number Publication date
ES2068384T3 (es) 1995-04-16
YU53290A (sh) 1992-12-21
FI914419A7 (fi) 1991-09-19
HU902706D0 (en) 1991-12-30
HUT58349A (en) 1992-02-28
EP0463072A1 (en) 1992-01-02
PT93502B (pt) 1996-02-29
ATE116661T1 (de) 1995-01-15
IL93792A0 (en) 1990-12-23
AU5344890A (en) 1990-10-22
DD298788A5 (de) 1992-03-12
PT93502A (pt) 1990-11-07
NO300640B1 (no) 1997-06-30
DE69015811T2 (de) 1995-05-11
EP0463072B1 (en) 1995-01-04
IE66564B1 (en) 1996-01-24
KR920701250A (ko) 1992-08-11
GR1002545B (el) 1997-01-28
NZ232953A (en) 1992-10-28
CA2049961A1 (en) 1990-09-21
IE901004L (en) 1990-09-20
DK134189D0 (da) 1989-03-20
ZA902086B (en) 1990-11-28
NO913687D0 (no) 1991-09-19
DK0463072T3 (da) 1995-06-12
AU637365B2 (en) 1993-05-27
CN1045793A (zh) 1990-10-03
DE69015811D1 (de) 1995-02-16
WO1990011299A1 (en) 1990-10-04
US5430016A (en) 1995-07-04
GR900100206A (el) 1991-07-31
FI914419A0 (fi) 1991-09-19
JPH04503808A (ja) 1992-07-09

Similar Documents

Publication Publication Date Title
NO913687D0 (no) Nye insulinforbindelser.
ES2188767T3 (es) Composicion a base de oxido de circonio y de oxido de cerio, procedimiento de preparacion y utilizacion.
ATE90107T1 (de) Peptide mit collagenase hemmender wirkung.
AU4799793A (en) Beta -aminoalkyl and beta -n-peptidylaminoalkyl boronic acids
HUT56558A (en) Process for producing oxetanones
ATE169678T1 (de) Stabilisierte enzyme
AU6954887A (en) Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use
HU9401584D0 (en) Preparation of substituted piperidines
IT1249732B (it) Oligonucleotidi antisenso.
NO971621D0 (no) Keratinocyttvekstfaktoranaloger
ES8602626A1 (es) Procedimiento de preparar compuestos oxima o-substituida
IL74114A0 (en) Process for the preparation of alkanephosphonous acids
DE69814837D1 (de) Verfahren zur Herstellung von Heteroaryl-Zink-Halogeniden
MX173831B (es) Compuestos de naftil-azo-pirazolona y procedimiento para la preparacion de los mismos
DK0779895T3 (da) Forbedret fremgangsmåde til fremstilling af sidekædederivater af cyclohexapeptidyl-lipopeptider
DK0661263T3 (da) Fremgangsmåde til fremstilling af 2,4,5-tribrompyrrol-3-carbonitril
DE69608260D1 (en) Wässrige spectinomycinborat-auflösung
AU6478194A (en) Ureins derived from alpha,omega-diamino acids and process for their preparation
ES2110839T3 (es) Copolimeros a base de dicetenos, acidos dicarboxilicos, o bien derivados de acidos dicarboxilicos etilenicamente insaturados, e hidrocarburos etilenicamente insaturados.
PT101847A (pt) Peptido substituido derivado de lisina e prolina
FI874677A7 (fi) Laekemedel anvaendbart vid behandling av magsaor.
DK0635021T3 (da) Fremgangsmåde til fremstilling af derivater af bis(aminomethyl)phosphinsyre
JPS5618971A (en) Alpha-halogeno-beta-benzosulfimidopropionitrile and its preparation
EP0506971A4 (en) Peptide with activity of inhibiting phospholipase a2 originating in inflamed part
JPS5283829A (en) Cyclic compound